Abbas, A.T.; El-Kafrawy, S.A.; Sohrab, S.S.; Tabll, A.A.; Hassan, A.M.; Iwata-Yoshikawa, N.; Nagata, N.; Azhar, E.I.
Anti-S1 MERS-COV IgY Specific Antibodies Decreases Lung Inflammation and Viral Antigen Positive Cells in the Human Transgenic Mouse Model. Vaccines 2020, 8, 634.
https://doi.org/10.3390/vaccines8040634
AMA Style
Abbas AT, El-Kafrawy SA, Sohrab SS, Tabll AA, Hassan AM, Iwata-Yoshikawa N, Nagata N, Azhar EI.
Anti-S1 MERS-COV IgY Specific Antibodies Decreases Lung Inflammation and Viral Antigen Positive Cells in the Human Transgenic Mouse Model. Vaccines. 2020; 8(4):634.
https://doi.org/10.3390/vaccines8040634
Chicago/Turabian Style
Abbas, Aymn T., Sherif A. El-Kafrawy, Sayed Sartaj Sohrab, Ashraf A. Tabll, Ahmed M. Hassan, Naoko Iwata-Yoshikawa, Noriyo Nagata, and Esam I. Azhar.
2020. "Anti-S1 MERS-COV IgY Specific Antibodies Decreases Lung Inflammation and Viral Antigen Positive Cells in the Human Transgenic Mouse Model" Vaccines 8, no. 4: 634.
https://doi.org/10.3390/vaccines8040634
APA Style
Abbas, A. T., El-Kafrawy, S. A., Sohrab, S. S., Tabll, A. A., Hassan, A. M., Iwata-Yoshikawa, N., Nagata, N., & Azhar, E. I.
(2020). Anti-S1 MERS-COV IgY Specific Antibodies Decreases Lung Inflammation and Viral Antigen Positive Cells in the Human Transgenic Mouse Model. Vaccines, 8(4), 634.
https://doi.org/10.3390/vaccines8040634
